CISA KEV: IBM / Aspera Faspex / IBM Aspera Faspex Incorrect Authorization Vulnerability
retained text
CVE: CVE-2026-123218 Vendor/project: IBM Product: Aspera Faspex Known ransomware campaign use: Unknown Due date: 2026-11-12 CWE: CWE-863 IBM Aspera Faspex contains an incorrect authorization vulnerability that could allow an authenticated user to craft a specific message to bypass authorization, causing privilege escalations. Required action: Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines. References: https://www.ibm.com/support/pages/node/7295921 https://www.cisa.gov/news-events/directives/bod-26-04-prioritizing-security-updates-based-risk https://www.cisa.gov/news-events/directives/bod-26-04-implementation-guidance-prioritizing-security-updates-based-risk https://nvd.nist.gov/vuln/detail/CVE-2026-123218
document fetched 2026-11-10 02:33 · canonical https://cisa.gov/known-exploited-vulnerabilities-catalog?search_api_fulltext=CVE-2026-123218